Quantitative determination of bilobetin in rat plasma by HPLC-MS/MS and its application to a pharmacokinetic study

Biomed Chromatogr. 2020 Apr;34(4):e4784. doi: 10.1002/bmc.4784. Epub 2020 Jan 20.

Abstract

Although bilobetin, a biflavone isolated from the leaves of Ginkgo biloba, represents a variety of pharmacological activities, to date there have been no validated determination methods for bilobetin in biological samples. Thus, we developed a liquid chromatographic method using a tandem mass spectrometry for the determination of bilobetin in rat plasma. After protein precipitation with acetonitrile including diclofenac (internal standard), the analytes were chromatographed on a reversed-phased column with a mobile phase of purified water and acetonitrile (3:7, v/v, including 0.1% formic acid). The ion transitions of the precursor to the product ion were principally deprotonated ions [M - H]- at m/z 551.2 → 519.2 for bilobetin and 296.1 → 251.7 for the IS. The accuracy and precision of the assay were in accordance with US Food and Drug Administration regulations for the validation of bioanalytical methods. This analytical method was successfully applied to monitor plasma concentrations of bilobetin over time following intravenous administration in rats.

Keywords: HPLC-MS/MS; bilobetin; intravenous; rat.

MeSH terms

  • Administration, Intravenous
  • Animals
  • Chromatography, High Pressure Liquid / methods*
  • Flavonoids / blood*
  • Flavonoids / chemistry
  • Flavonoids / pharmacokinetics*
  • Limit of Detection
  • Linear Models
  • Rats
  • Reproducibility of Results
  • Tandem Mass Spectrometry / methods*

Substances

  • Flavonoids
  • bilobetin